FDA.reportPublic FDA data

Aptivus 250 MG Oral Capsule

RxCUI
603378
RxNorm name
Aptivus 250 MG Oral Capsule
Display name
Aptivus 250 MG Oral Capsule
Full name
Aptivus 250 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
08982e49-d2eb-4b25-b01a-1be52fd669efAptivus 250 MG Oral Capsule [PSN] · tipranavir 250 MG Oral Capsule [Aptivus] [SBD] · Aptivus 250 MG Oral Capsule [SY]319These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUS® (tipranavir) capsules, for oral use Initial U.S. Approval: 200520250618